-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JNBiv3dnLo9SQbCyvJocnb0sktzi0sdHPoKHfLehz2ne3hlcLsQwmmM8p6de+We3 HCxtaa78idgDDPoTvR8vmQ== 0001171843-08-000112.txt : 20080212 0001171843-08-000112.hdr.sgml : 20080212 20080212083310 ACCESSION NUMBER: 0001171843-08-000112 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080212 ITEM INFORMATION: Other Events FILED AS OF DATE: 20080212 DATE AS OF CHANGE: 20080212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19974 FILM NUMBER: 08595766 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763 8-K 1 document.htm FORM 8-K FILING DOCUMENT Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 12, 2008


ICU Medical, Inc.
(Exact name of registrant as specified in its charter)


DELAWARE
 
0-19974
 
33-0022692
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)


 
951 Calle Amanecer, San Clemente, California
 
92673
 
  (Address of principal executive offices)   (Zip Code)  

Registrant's telephone number, including area code:   (949) 366-2183



________________________________________________________________________________
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

See attached press release.

Item 9.01. Financial Statements and Exhibits.

(c) Exhibits

99.1 Press release, dated February 12, 2008 announcing ICU Medical, Inc.’s presentation at the ROTH 20th Annual OC Growth Stock Conference.


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ICU Medical, Inc.
(Registrant)

February 12, 2008
(Date)
  /s/   FRANCIS J. O'BRIEN
Francis J. O'Brien
Secretary, Treasurer and Chief Financial Officer
EX-99.1 2 newsrelease.htm PRESS RELEASE ICU Medical, Inc. to Present at the ROTH 20th Annual OC Growth Stock Conference

EXHIBIT 99.1

ICU Medical, Inc. to Present at the ROTH 20th Annual OC Growth Stock Conference

SAN CLEMENTE, Calif., Feb. 12, 2008 (PRIME NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, today announced that it will present at the ROTH 20th Annual Growth Stock Conference to be held on February 18 - 21, 2008, at the Ritz Carlton, Laguna Niguel, California.

ICU Medical's presentation is scheduled for Wednesday, February 20, 2008 at 3:00 p. m. Pacific Time.

The presentation will be webcast live and can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, linking on the Webcast icon and following the prompts. The webcast will also be available by replay.

CONTACT:  ICU Medical, Inc.
          Francis J. O'Brien, Chief Financial Officer
          (949) 366-2183

          Integrated Corporate Relations
          John F. Mills, Managing Director
          (310) 395-1100
-----END PRIVACY-ENHANCED MESSAGE-----